Morgan Stanley »

Silence Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.8M 304k 19.00
2024-03-31 $5.2M 243k 21.60
2023-12-31 $1.1M 63k 17.37
2023-09-30 $523k 53k 9.82
2023-06-30 $361k 66k 5.50
2022-12-31 $3.2M 211k 15.25
2022-06-30 $1.8M 153k 11.85
2022-03-31 $2.9M 152k 19.00
2021-06-30 $250k 9.6k 26.14
2020-12-31 $44k 2.0k 22.00
2020-09-30 $32k 2.0k 16.00